Switching to Dolutegravir/Lamivudine Two-Drug Regimen: Durability and Virologic Outcomes by Age, Sex, and Race in Routine US Clinical Care

Autor: Pierone G Jr, Brunet L, Fusco JS, Henegar CE, Sarkar S, Van Wyk J, Vannappagari V, Wohlfeiler MB, Fusco GP

Publikováno v: HIV/AIDS: Research and Palliative Care, Vol Volume 16, Pp 133-140 (2024)

Gerald Pierone Jr,1 Laurence Brunet,2 Jennifer S Fusco,2 Cassidy E Henegar,3 Supriya Sarkar,3 Jean Van Wyk,4 Vani Vannappagari,3 Michael B Wohlfeiler,5 Gregory P Fusco2 1Department of Adult Primary Care, Whole Family Health Center, Vero Beach, FL, US

Externí odkaz: https://doaj.org/article/5c87bc8536824d33b72cfa113af30426

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Diet in a global cohort of adults with HIV at low-to-moderate traditional cardiovascular disease risk.

Autor: Fitch KV; Massachusetts General Hospital, Boston, MA., McCallum SA; Massachusetts General Hospital, Boston, MA., Erlandson KM; University of Colorado, Anschutz Medical Campus, Aurora, CO., Overton ET; University of Alabama at Birmingham, Birmingham, AL., Zanni MV; Massachusetts General Hospital, Boston, MA., Fichtenbaum C; University of Cincinnati, Cincinnati, OH., Aberg JA; Icahn School of Medicine at Mount Sinai, New York, NY., Fulda ES; Massachusetts General Hospital, Boston, MA., Kileel EM; Massachusetts General Hospital, Boston, MA., Moran LE; Social & Scientific Systems, a DLH Company, Silver Spring, MD., Bloomfield GS; Duke Global Health Institute, Durham, NC.; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC., Novak RM; University of Illinois at Chicago, Chicago, IL., Pérez-Frontera S; University of Puerto Rico, Medical Sciences Campus, School of Medicine, San Juan, PR., Abrams-Downey A; Icahn School of Medicine at Mount Sinai, New York, NY., Pierone G Jr; AIDS Research and Treatment Center of the Treasure Coast, Vero Beach, FL, USA., Kumarasamy N; Chennai Antiviral Research and Treatment CRS, Voluntary Health Services, Chennai, India., Ruxrungtham K; School of Global Faculty of Medicine Chulalongkorn University and HIV-NAT Research Collaboration, Thai Red Cross AIDS Research Centre, Bangkok, Thailand., Mngqibisa R; Enhancing Care Foundation (Wentworth Hospital), Durban, South Africa., Douglas PS; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC., Ribaudo HJ; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Grinspoon SK; Massachusetts General Hospital, Boston, MA.

Publikováno v: AIDS (London, England) [AIDS] 2022 Nov 15; Vol. 36 (14), pp. 1997-2003. Date of Electronic Publication: 2022 Jul 27.

Efficacy, Safety, and Tolerability of Switching From Bictegravir/Emtricitabine/Tenofovir Alafenamide to Dolutegravir/Lamivudine Among Adults With Virologically Suppressed HIV: The DYAD Study.

Autor: Rolle, Charlotte-Paige^1,2 (AUTHOR) crolle@oicorlando.com, Castano, Jamie¹ (AUTHOR), Nguyen, Vu¹ (AUTHOR), Hinestrosa, Federico^1,3 (AUTHOR) crolle@oicorlando.com, DeJesus, Edwin^1,3 (AUTHOR)

Publikováno v: Open Forum Infectious Diseases. Oct2024, Vol. 11 Issue 10, p1-10. 10p.

Difcult-to-treat HIV in Sweden: a cross-sectional study.

Autor: Elvstam, Olof^1,2 (AUTHOR) olof.elvstam@med.lu.se, Dahl, Viktor³ (AUTHOR), Wärnberg, Anna Weibull⁴ (AUTHOR), von Stockenström, Susanne⁵ (AUTHOR), Yilmaz, Aylin^6,7 (AUTHOR)

Publikováno v: BMC Infectious Diseases. 3/18/2024, Vol. 24 Issue 1, p1-8. 8p. 2 Charts, 2 Graphs.